IONS
IONIS PHARMACEUTICALS INC
Key Financials
Revenue
$203.3M
↓ 10.3%
Net Income
$-381387000
↓ 66.3%
Operating Income
$-381684000
↓ 78.0%
Total Assets
$3.5B
↑ 17.3%
Shareholders' Equity
$489.1M
↓ 16.9%
EPS (Diluted)
$-2.38
↓ 68.8%
Total Liabilities
$3.0B
↑ 25.6%
Cash & Equivalents
$372.3M
↑ 53.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 144 | 5/13/2026 | View on SEC |
| 4 | 5/6/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| 144 | 5/4/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| 10-Q | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IONS |
| Company Name | IONIS PHARMACEUTICALS INC |
| CIK | 874015 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | CA |
| Phone | 7609319200 |